Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Chemotherapeutic agents for colorectal cancer with a defective mismatch repair system: The state of the art

19 Oct 2006

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Colorectal Cancer Treatments and Studies
Share to Genetic factors in colorectal cancer

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 17055172
DOI: 10.1016/j.ctrv.2006.08.001

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Chemotherapeutic agents for colorectal cancer with a defective mismatch repair system: The state of the artPMID 17055172Read ↗

Mismatch repair deficient colorectal cancer in the era of personalized treatment.Semantic proximity Read ↗

Deficient mismatch repair/microsatellite unstable colorectal cancer: Diagnosis, prognosis and treatmentSemantic proximity Read ↗

The current value of determining the mismatch repair status of colorectal cancer: A rationale for routine testingSemantic proximity Read ↗

Validation of a targeted next-generation sequencing approach to detect mismatch repair deficiency in colorectal adenocarcinomaSemantic proximity Read ↗

Advances in DNA damage response inhibitors in colorectal cancer therapySemantic proximity Read ↗

Recommendations on surveillance and management of biallelic mismatch repair deficiency (BMMRD) syndrome: a consensus statement by the US Multi-Society Task Force on Colorectal Cancer.Semantic proximity Read ↗

Oncological characteristics, treatments and prognostic outcomes in MMR-deficient colorectal cancerSemantic proximity Read ↗

Exploiting DNA repair defects in colorectal cancerSemantic proximity Read ↗

Nucleotide excision repair and response and survival to chemotherapy in colorectal cancer patients.Semantic proximity Read ↗

Heterogeneity of mismatch repair defect in colorectal cancer and its implications in clinical practiceSemantic proximity Read ↗

Assessing colorectal cancer mismatch repair status in the modern era: a survey of current practices and re-evaluation of the role of microsatellite instability testingSemantic proximity Read ↗

Biomarkers for chemotherapy and drug resistance in the mismatch repair pathwaySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.